NCT00558649View on ClinicalTrials.gov

A Pilot Study to Evaluate the Safety and Immunogenicity of Low Dose Flu Vaccines

NACompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

September 30, 2007

Study Completion Date

December 31, 2007

Conditions
Influenza, Human
Interventions
BIOLOGICAL

Flu Vaccine (FLUARIX®)

Influenza Virus Vaccine, FLUARIX®, 2006-2007 Formula

Sponsors
All Listed Sponsors
lead

NanoPass Technologies Ltd

INDUSTRY

NCT00558649 - A Pilot Study to Evaluate the Safety and Immunogenicity of Low Dose Flu Vaccines | Biotech Hunter | Biotech Hunter